Modulo Bio
Pre-clinicalModulo is decoding the neuroimmune system. Applying science and engineering to identify new treatment paths for neurodegenerative diseases.
Founded
2021
Focus
Small Molecules
About
Modulo is decoding the neuroimmune system. Applying science and engineering to identify new treatment paths for neurodegenerative diseases.
Funding History
1Total raised: $8M
Seed$8MUndisclosedJun 15, 2023
Company Info
TypePrivate
Founded2021
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile